Principales conclusions et analyse des parts de marché de la thalassémie d'ici 2025-2031
Thalassemia Market Report Analysis
Thalassemia Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Bluebird Bio, Inc.
- Acceleron Pharma, Inc.
- GlaxoSmithKline plc.
- La Jolla Pharmaceutical Company
- Incyte Corporation
- IONIS Pharmaceuticals
- Kiadis Pharma
- Sangamo Bioscience
- Lonza Group Ltd.
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Type de traitement
- transfusions sanguines
- thérapie par chélation du fer
- suppléments d'acide folique
- greffes de moelle osseuse
By Type de maladie
- alpha-thalassémie
- bêta-thalassémie
By Utilisateur final
- hôpitaux
- instituts de recherche
- laboratoires de diagnostic
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For